Medical Condition

solid tumors

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 1, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for solid tumors sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — solid tumors Clinical Trials

How many clinical trials are currently recruiting for solid tumors?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for solid tumors, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for solid tumors?

solid tumors research spans Phase 1 (9 trials), Phase 2 (4 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a solid tumors clinical trial?

Eligibility criteria for solid tumors trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Daiichi Sankyo 2 trials

Zai Lab (Shanghai) Co., Ltd. 1 trial

Seqker Biosciences, Inc. 1 trial

Boehringer Ingelheim 1 trial

BeOne Medicines 1 trial

Recruiting Clinical Trials

NCT06885281 Phase 1, Phase 2

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

Zai Lab (Shanghai) Co., Ltd.

View Trial →

NCT07002203 Phase 1, Phase 2

Recruiting

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Seqker Biosciences, Inc.

View Trial →

NCT05471856 Phase 1

Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Enrollment

66 pts

Location

United States, Japan...

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Enrollment

63 pts

Location

United States, Austr...

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Enrollment

150 pts

Location

United States, Belgi...

A Study of DS3610a in Participants With Advanced Solid Tumor

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Enrollment

170 pts

Location

United States, Austr...

Sponsor

Mirati Therapeutics Inc.

View Trial →

NCT01166009

Recruiting

CIBMTR Research Database

Center for International Blood...

View Trial →

NCT06632262 Phase 2

Recruiting

A Phase 2 Clinical Study of ABSK061 and ABSK043

Abbisko Therapeutics Co, Ltd

View Trial →

NCT07529002

Recruiting

Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors

Peking University Cancer Hospi...

View Trial →

NCT07232407 Phase 1

Recruiting

A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Sichuan Baili Pharmaceutical C...

View Trial →

NCT05203172 Phase 4

Recruiting

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Enrollment

46 pts

Location

United States, Austr...

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Enrollment

280 pts

Location

United States, Austr...

Sponsor

Incyte Corporation

View Trial →

Related Conditions

advanced cancer (1) recurrent cancer (1) neoantigen specific immunotherapy (1) personalized cancer vaccine (1) advanced solid tumor (1) gastric cancer (1) esophagogastric juction cancer (1) colorectal cancer (1) sarcoma (1) metastatic solid tumors (1) autologous stem cell transplantation (1) allogeneic stem cell transplantation (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology